End-stage renal disease (ESRD) contributes to the increasing prevalence of herpes zoster

NDT Plus

Volumn 2, Issue 3, 2009, Pages 263-264

  Sato, Takahiko ^a   Inoue, Tsutomu ^a   Endo, Kei ^a   Watanabe, Yusuke ^a   Kikuta, Tomohiro ^a   Tsuda, Masahiro ^a   Arai, Jonde ^a   Kobayashi, Kazuhiro ^a   Ikeda, Naofumi ^a   Ohno, Yoichi ^a   Takenaka, Tsuneo ^a   Suzuki, Hiromichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE COURSE; FEMALE; HEMODIALYSIS; HERPES ZOSTER; HUMAN; INCIDENCE; KIDNEY FAILURE; LETTER; MALE; PREVALENCE; PRIORITY JOURNAL; UREMIA;

EID: 77953931972     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp024     Document Type: Letter

References (6)

1. Straus SE, Ostrove JM, Inchauspe G et al. NIH conference. Varicellazoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108: 221-237
2. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32: 1481-1486
3. Buchbinder SP, Katz MH, Hessol NA et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992; 166: 1153-1156
4. Miller GG, Dummer JS. Herpes simplex and varicella zoster viruses: forgotten but not gone. Am J Transplant 2007; 7: 741-747
5. Yawn BP, Saddier P, Wollan PC et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82: 1341-1349
6. Girndt M, Sester M, Sester U et al. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 2001; 78: S206-S211